Literature DB >> 31770056

Successful Administration of Cemiplimab to a Patient With Advanced Cutaneous Squamous Cell Carcinoma After Renal Transplantation.

Saad Ahmad Ali1, Huseyin Emre Arman1, Anuj Amrut Patel2, Ruemu Ejedafeta Birhiray3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31770056     DOI： 10.1200/JOP.19.00567

Source DB:  PubMed          Journal:  JCO Oncol Pract        ISSN： 2688-1527


× No keyword cloud information.
  2 in total

1.  Safe Administration of Cemiplimab to a Kidney Transplant Patient with Locally Advanced Squamous Cell Carcinoma of the Scalp.

Authors:  Luca Paoluzzi; Thomas J Ow
Journal:  Curr Oncol       Date:  2021-01-19       Impact factor: 3.677

2.  Cemiplimab for Locally Advanced Cutaneous Squamous Cell Carcinoma: A Case Series of 3 Unique Scenarios.

Authors:  Komal Akhtar; Metlapalli Venkata Sravanthi; Josephine D'Angelo; Abirami Sivapiragasam
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.